Product NDC: | 0075-2451 |
Proprietary Name: | DDAVP |
Non Proprietary Name: | desmopressin acetate |
Active Ingredient(s): | 4 ug/mL & nbsp; desmopressin acetate |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0075-2451 |
Labeler Name: | sanofi-aventis U.S. LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA018938 |
Marketing Category: | NDA |
Start Marketing Date: | 19840330 |
Package NDC: | 0075-2451-53 |
Package Description: | 1 VIAL, MULTI-DOSE in 1 CARTON (0075-2451-53) > 10 mL in 1 VIAL, MULTI-DOSE |
NDC Code | 0075-2451-53 |
Proprietary Name | DDAVP |
Package Description | 1 VIAL, MULTI-DOSE in 1 CARTON (0075-2451-53) > 10 mL in 1 VIAL, MULTI-DOSE |
Product NDC | 0075-2451 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | desmopressin acetate |
Dosage Form Name | SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 19840330 |
Marketing Category Name | NDA |
Labeler Name | sanofi-aventis U.S. LLC |
Substance Name | DESMOPRESSIN ACETATE |
Strength Number | 4 |
Strength Unit | ug/mL |
Pharmaceutical Classes | Factor VIII Activator [EPC],Increased Coagulation Factor VIII Activity [PE],Increased Coagulation Factor VIII Concentration [PE],Vasopressin Analog [EPC],Vasopressins [Chemical/Ingredient] |